<DOC>
	<DOCNO>NCT00838487</DOCNO>
	<brief_summary>Primary Objective : To compare , 12 week double-blind treatment , evolution improvement pain ( rest / exercise ) questionnaire WOMAC ( Western Ontario McMaster Universities Arthritis Index ) , achieve Condroflex Â® oral administration ( sulfate glucosamine + chondroitin sulfate sodium ) association therapeutic exercise , compare placebo association therapeutic exercise individual knee OA expose prior treatment product investigation .</brief_summary>
	<brief_title>Evaluate Safety &amp; Efficacy Condroflex Subjects With OA</brief_title>
	<detailed_description>To osteoarthritis degree 2 3 / To capable consent</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>knee osteoarthritis degree 2 3 capable consent previous drug treatment concomitant diseases concomitant drug</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>chondroitin</keyword>
	<keyword>glucosamine</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>